The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE
Abstract
Late-onset Alzheimer's disease (LOAD) is the most common form of dementia in the elderly. The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. This cohort represents the largest family-based GWAS of LOAD to date, with analyses limited here to the European-American subjects. SNPs near APOE gave highly significant results (e.g., rs2075650, p = 3.2×10(-81)), but no other genome-wide significant evidence for association was obtained in the full sample. Analyses that stratified on APOE genotypes identified SNPs on chromosome 10p14 in CUGBP2 with genome-wide significant evidence for association within APOE ε4 homozygotes (e.g., rs201119, p = 1.5×10(-8)). Association in this gene was replicated in an independent sample consisting of three cohorts. There was evidence of association for recently-reported LOAD risk loci, including BIN1 (rs7561528, p = 0.009 with, and p = 0.03 without, APOE adjustment) and CLU (rs11136000, p = 0.023 with, and p = 0.008 without, APOE adjustment), with weaker support for CR1. However, our results provide strong evidence that association with PICALM (rs3851179, p = 0.69 with, and p = 0.039 without, APOE adjustment) and EXOC3L2 is affected by correlation with APOE, and thus may represent spurious association. Our results indicate that genetic structure coupled with ascertainment bias resulting from the strong APOE association affect genome-wide results and interpretation of some recently reported associations. We show that a locus such as APOE, with large effects and strong association with disease, can lead to samples that require appropriate adjustment for this locus to avoid both false positive and false negative evidence of association. We suggest that similar adjustments may also be needed for many other large multi-site studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CELF2 (CUGP2) and PICALM are also risk factors for AD that are members of the oTau PPI network (Harold et al., 2009; Wijsman et al., 2011); PICALM has been shown to regulate tau accumulation (Moreau et al., 2014).”
From Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy (2021) · cites this paper as Wijsman et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citationCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationGenomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162 · cited 2×
“We therefore corrected the cross-strata tests by dividing by l as a genome control correction factor [74].”
MethodCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citation
Research works printed but not linked: 67
- R Mayeux, 2003, Epidemiology of neurodegeneration., Annu Rev Neurosci, 26, 81, 10.1146/annurev.neuro.26.043002.094919 · DOI · Paper page
- L Fratiglioni, 1999, Worldwide prevalence and incidence of dementia., Drugs & Aging, 15, 365, 10.2165/00002512-199915050-00004 · DOI · Paper page
- ALM Bergem, 1997, Apolipoprotein E type epsilon 4 allele, heritability and age at onset in twins with Alzheimer's disease., Clin Genet, 52, 408, 10.1111/j.1399-0004.1997.tb04362.x · DOI
- JM Meyer, 1998, Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel., Am J Med Genet, 81, 92, 10.1002/(SICI)1096-8628(19980207)81:1<92::AID-AJMG16>3.0.CO;2-R · DOI
- HO Akesson, 1969, A Population Study of Senile and Arteriosclerotic Psychoses., Hum Hered, 19, 546, 10.1159/000152266 · DOI
- JCS Breitner, 1986, Familial Aggregation in Alzheimer Dementia .1. a Model for the Age-Dependent Expression of an Autosomal Dominant Gene., J Psychiatr Res, 20, 31, 10.1016/0022-3956(86)90021-X · DOI
- RC Mohs, 1987, Alzheimers-Disease - Morbid Risk among 1st-Degree Relatives Approximates 50-Percent by 90 Years of Age., Arch Gen Psychiatry, 44, 405, 10.1001/archpsyc.1987.01800170019003 · DOI
- C Van Broeckhoven, 1987, Failure of Familial Alzheimers-Disease to Segregate with the A4-Amyloid Gene in Several European Families., Nature, 329, 153, 10.1038/329153a0 · DOI · Paper page
- TD Bird, 1988, Familial Alzheimer's disease in american descendants of the Volga Germans: probable genetic founder effect., Ann Neurol, 23, 25, 10.1002/ana.410230106 · DOI
- PH St. George-Hyslop, 1989, Familial Alzheimers-Disease - Progress and Problems., Neurobiol Aging, 10, 417, 10.1016/0197-4580(89)90082-1 · DOI
- EW Daw, 1999, Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer's disease pedigrees., Am J Hum Genet, 64, 839, 10.1086/302276 · DOI
- EW Daw, 2000, The number of trait loci in late-onset Alzheimer disease., Am J Hum Genet, 66, 196, 10.1086/302710 · DOI · Paper page
- MA Pericak-Vance, 2000, Identification of Novel Genes in Late-Onset Alzheimer's Disease., Exp Gerontol, 35, 1343, 10.1016/S0531-5565(00)00196-0 · DOI · Paper page
- D Blacker, 2003, Results of a high-resolution genome screen of 437 Alzheimer's Disease families., Hum Mol Genet, 12, 23, 10.1093/hmg/ddg007 · DOI · Paper page
- LA Farrer, 2003, Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community., Hum Mol Genet, 12, 415, 10.1093/hmg/ddg037 · DOI
- WK Scott, 2003, Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22., Am J Hum Genet, 73, 1041, 10.1086/379083 · DOI
- EM Wijsman, 2004, Evidence for a novel late-onset Alzheimer's disease locus on chromosome 19p13.2., Am J Hum Genet, 75, 398, 10.1086/423393 · DOI · Paper page
- L Bertram, 2005, Family-based association between Alzheimer's disease and variants in UBQLN1., N Engl J Med, 352, 884, 10.1056/NEJMoa042765 · DOI · Paper page
- R Rademakers, 2005, Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample., Am J Hum Genet, 77, 643, 10.1086/491749 · DOI
- DW Hahs, 2006, A genome-wide linkage analysis of dementia in the Amish., Am J Med Genet B Neuropsychiatr Genet, 141B, 160, 10.1002/ajmg.b.30257 · DOI
- JH Lee, 2006, Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean Hispanics with familial Alzheimer disease., Arch Neurol, 63, 1591, 10.1001/archneur.63.11.1591 · DOI
- Y Li, 2006, DAPK1 variants are associated with Alzheimer's disease and allele-specific expression., Hum Mol Genet, 15, 2560, 10.1093/hmg/ddl178 · DOI
- AW Butler, 2009, Meta-analysis of linkage studies for Alzheimer's disease-A web resource., Neurobiol Aging, 30, 1037, 10.1016/j.neurobiolaging.2009.03.013 · DOI
- A Grupe, 2007, Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants., Hum Mol Genet, 16, 865, 10.1093/hmg/ddm031 · DOI · Paper page
- EM Reiman, 2007, GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers., Neuron, 54, 713, 10.1016/j.neuron.2007.05.022 · DOI · Paper page
- SE Poduslo, 2009, Genome screen of late-onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis., Am J Med Genet B Neuropsychiatr Genet, 150B, 50, 10.1002/ajmg.b.30767 · DOI
- JC Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease., Nat Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
- S Seshadri, 2010, Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease., JAMA, 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
- GP Jarvik, 1996, Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample., Am J Hum Genet, 58, 191
- AJC Slooter, 1997, Genetic epidemiology of Alzheimer disease., Epidemiol Rev, 19, 107, 10.1093/oxfordjournals.epirev.a017933 · DOI
- M McCarthy, 1998, Sib-pair collection strategies for complex diseases., Genet Epidemiol, 15, 317, 10.1002/(SICI)1098-2272(1998)15:4<317::AID-GEPI1>3.0.CO;2-# · doi:10.1002/(sici)1098-2272(1998)15:4<317::aid-gepi1>3.0.co;2-#
- G McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease., Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- A Chudyk, 2006, Soluble HLA class I molecules exert differentiated influence on renal graft condition., Transplant Proc, 38, 90, 10.1016/j.transproceed.2005.11.090 · DOI
- MV Myakishev, 2001, High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers., Genome Res, 11, 163, 10.1101/gr.157901 · DOI · Paper page
- JR Hawkins, 2002, Miniaturized sealed-tube allele-specific PCR., Hum Mutat, 19, 543, 10.1002/humu.10060 · DOI
- LM Bekris, 2008, Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels., J Alzheimers Dis, 13, 255, 10.3233/JAD-2008-13303 · DOI · Paper page
- HHH Göring, 1997, Relationship estimation in affected rib pair analysis of late-onset diseases., Eur J Hum Genet, 5, 69, 10.1159/000484736 · DOI
- L Sun, 2002, Enhanced pedigree error detection., Hum Hered, 54, 99, 10.1159/000067666 · DOI
- DM Nielsen, 1998, Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus., Am J Hum Genet, 63, 1531, 10.1086/302114 · DOI · Paper page
- JK Wittke-Thompson, 2005, Rational inferences about departures from Hardy-Weinberg equilibrium., Am J Hum Genet, 76, 967, 10.1086/430507 · DOI · Paper page
- GY Zou, 2006, The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: A cautionary note., Ann Hum Genet, 70, 923, 10.1111/j.1469-1809.2006.00267.x · DOI
- CB Harvey, 1998, Lactase haplotype frequencies in Caucasians: association with the lactase persistence/non-persistence polymorphism., Ann Hum Genet, 62, 215, 10.1046/j.1469-1809.1998.6230215.x · DOI
- EJ Hollox, 2001, Lactase haplotype diversity in the Old World., Am J Hum Genet, 68, 160, 10.1086/316924 · DOI · Paper page
- Y Choi, 2009, Case-control Association Testing in the Presence of Unknown Relationships., Genet Epidemiol, 35, 668, 10.1002/gepi.20418 · DOI
- A Jacquard, 1972, Genetic Information Given by a Relative., Biometrics, 28, 1101, 10.2307/2528643 · DOI
- BG Milligan, 2003, Maximum-likelihood estimation of relatedness., Genetics, 163, 1153, 10.1093/genetics/163.3.1153 · DOI · Paper page
- C Bourgain, 2003, Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus., Am J Hum Genet, 73, 612, 10.1086/378208 · DOI
- JK Pritchard, 2001, Case-control studies of association in structured or admixed populations., Theor Popul Biol, 60, 227, 10.1006/tpbi.2001.1543 · DOI · Paper page
- JM Chapman, 2003, Detecting disease associations due to linkage disequilibrium using haplotype tags: A class of tests and the determinants of statistical power., Hum Hered, 56, 18, 10.1159/000073729 · DOI · Paper page
- CE Yu, 2007, Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association., Genomics, 89, 655, 10.1016/j.ygeno.2007.02.002 · DOI
- SN Romas, 2002, Familial Alzheimer disease among Caribbean Hispanics - A reexamination of its association with APOE., Arch Neurol, 59, 87, 10.1001/archneur.59.1.87 · DOI
- NA Rosenberg, 2009, Replication of Genetic Associations as Pseudoreplication due to Shared Genealogy., Genet Epidemiol, 33, 479, 10.1002/gepi.20400 · DOI
- SC Heath, 2008, Investigation of the fine structure of European populations with applications to disease association studies., Eur J Hum Genet, 16, 1413, 10.1038/ejhg.2008.210 · DOI · Paper page
- G Lucotte, 1997, Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe., Hum Biol, 69, 253
- RM Corbo, 1999, Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?, Ann Hum Genet, 63, 301, 10.1046/j.1469-1809.1999.6340301.x · DOI · Paper page
- H Rosenmann, 2003, An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease., Neurosci Lett, 340, 29, 10.1016/S0304-3940(03)00049-1 · DOI
- R Dresner-Pollak, 2009, Estrogen Receptor Beta Gene Variant Is Associated with Vascular Dementia in Elderly Women., Genet Test Mol Biomarkers, 13, 339, 10.1089/gtmb.2008.0129 · doi:10.1089/gtmb.2008.0129
- J Little, 2009, Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement., Hum Genet, 125, 131, 10.1007/s00439-008-0592-7 · DOI · Paper page
- M Nelis, 2009, Genetic Structure of Europeans: A View from the North-East., PLoS ONE, 4, e5472, 10.1371/journal.pone.0005472 · DOI · Paper page
- L Zekraoui, 1997, High frequency of the apolipoprotein E *4 allele in African pygmies and most of the African populations in sub-Saharan Africa., Hum Biol, 69, 575
- BF Voight, 2005, Confounding from cryptic relatedness in case-control association studies., PLoS Genet, 1, e32, 10.1371/journal.pgen.0010032 · DOI · Paper page
- D Blacker, 2001, Results of a high resolution genome screen in 443 Alzheimer's disease families: the NIMH Genetics Initiative., Am J Hum Genet, 69, 498
- JH Lee, 2008, Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study Implication of Additional Loci., Arch Neurol, 65, 1518, 10.1001/archneur.65.11.1518 · DOI
- A Pacini, 2005, NAPOR-3 RNA binding protein is required for apoptosis in hippocampus., Brain Res Mol Brain Res, 140, 34, 10.1016/j.molbrainres.2005.07.006 · DOI
- A Falkevall, 2006, Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP., J Biol Chem, 281, 29096, 10.1074/jbc.M602532200 · DOI · Paper page
- G Jun, 2010, Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes., 10.1001/archneurol.2010.201 · DOI · Paper page
- J Wakefield, 2009, Bayes Factors for Genome-Wide Association Studies: Comparison with P-values., Genet Epidemiol, 33, 79, 10.1002/gepi.20359 · DOI · Paper page
Cited by
Epidemiology of Alzheimer Disease
Mayeux, R., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,064
Self-citationOverview and Findings from the Rush Memory and Aging Project
A. Bennett, D., A. Schneider, J., S. Buchman, A., L. Barnes, L., A. Boyle, P., & S. Wilson, R. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322663 · Cited by 862
Overview and Findings from the Religious Orders Study
A. Bennett, D., A. Schneider, J., Arvanitakis, Z., & S. Wilson, R. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322573 · Cited by 672
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473
Self-citationRare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., et al. (2014) · Nature · doi:10.1038/nature12825 · Cited by 461
Self-citationJun, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.201 · Cited by 422
Boza-Serrano, A., Ruiz, R., Sanchez-Varo, R., García-Revilla, J., Yang, Y., Jimenez-Ferrer, I., Paulus, A., Wennström, M., Vilalta, A., Allendorf, D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02013-z · Cited by 357
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
Cruchaga, C., Chakraverty, S., Mayo, K., Vallania, F. L. M., Mitra, R. D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031039 · Cited by 320
Self-citationGenetic insights in Alzheimer's disease
Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70259-4 · Cited by 290
Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
Villegas-Llerena, C., Phillips, A., Garcia-Reitboeck, P., Hardy, J., & Pocock, J. M. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.004 · Cited by 270
The biological pathways of Alzheimer disease: a review
Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) · AIMS Neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 265
Untangling Genetic Risk for Alzheimer’s Disease
Pimenova, A. A., Raj, T., & Goate, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.014 · Cited by 223
“been associated with AD risk in different populatio ns (32, 98, 99).”
BackgroundSelf-citationAncestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
Rajabli, F., Feliciano, B. E., Celis, K., Hamilton-Nelson, K. L., Whitehead, P. L., Adams, L. D., Bussies, P. L., Manrique, C. P., Rodriguez, A., Rodriguez, V., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007791 · Cited by 206
Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics
Verheijen, J., & Sleegers, K. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.02.007 · Cited by 192
Amphiphysin 2 (BIN1) in physiology and diseases
Prokic, I., Cowling, B. S., & Laporte, J. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1138-1 · Cited by 188
Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
Jiang, L., Lin, W., Zhang, C., Ash, P. E. A., Verma, M., Kwan, J., van Vliet, E., Yang, Z., Cruz, A. L., Boudeau, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.038 · Cited by 177
The Role of Clusterin in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy
Yu, J.-T., & Tan, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8237-1 · Cited by 174
Paulsen, J. S., Nance, M., Kim, J.-I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., McCusker, E., & Williams, J. K. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.003 · Cited by 168
Alzheimer's Disease Genetics Consortium, Wetzel-Smith, M. K., Hunkapiller, J., Bhangale, T. R., Srinivasan, K., Maloney, J. A., Atwal, J. K., Sa, S. M., B Yaylaoglu, M., Foreman, O., et al. (2014) · Nature Medicine · doi:10.1038/nm.3736 · Cited by 153
Self-citationVardarajan, B. N., Ghani, M., Kahn, A., Sheikh, S., Sato, C., Barral, S., Lee, J. H., Cheng, R., Reitz, C., Lantigua, R., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24466 · Cited by 148
Self-citationGenetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“Likewise, familial inheritance of AD is typically associated with early-onset forms of the disease, but large families with multiple individuals affected by LOAD are prevalent (Wijsman et al., 2011; Vardarajan et al., 2014).”
BackgroundSelf-citationThe BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Franzmeier, N., Rubinski, A., Neitzel, J., Ewers, M., (ADNI), T. A. D. N. I., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09564-5 · Cited by 109
Self-citationC9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Harms, M., Benitez, B. A., Cairns, N., Cooper, B., Cooper, P., Mayo, K., Carrell, D., Faber, K., Williamson, J., Bird, T., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.537 · Cited by 102
“Mach software24 was used to phase the 24 SNPs.”
BackgroundMethodInfluentialSelf-citationBIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging
Glennon, E. B. C., Whitehouse, I. J., Miners, J. S., Kehoe, P. G., Love, S., Kellett, K. A. B., & Hooper, N. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078806 · Cited by 81
Zhou, Y., Hayashi, I., Wong, J., Tugusheva, K., Renger, J. J., & Zerbinatti, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103187 · Cited by 72
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation
Jun, G., Asai, H., Zeldich, E., Drapeau, E., Chen, C., Chung, J., Park, J., Kim, S., Haroutunian, V., Foroud, T., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24219 · Cited by 67
“The NIA-LOAD Study recruited families with 2 affected members available for genotyping.(13) Phenotype and GWAS data for this cohort were obtained from dbGaP.”
MethodSelf-citationRoussotte, F. F., Gutman, B. A., Madsen, S. K., Colby, J. B., Thompson, P. M., & Initiative, F. T. A. D. N. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5236-13.2014 · Cited by 63
Toh, W. H., & Gleeson, P. A. (2016) · Biochemical Journal · doi:10.1042/bcj20160147 · Cited by 62
Lee, J. H., Cheng, R., Vardarajan, B., Lantigua, R., Reyes-Dumeyer, D., Ortmann, W., Graham, R. R., Bhangale, T., Behrens, T. W., Medrano, M., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1424 · Cited by 55
Self-citationAdams, S. L., Tilton, K., Kozubek, J. A., Seshadri, S., & Delalle, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw056 · Cited by 45
“Because late-onset Alzheimer disease (LOAD) has a largely unknown genetic component, genome-wide association studies have investigated thousands of human genomes to identify LOAD-associated risk loci (1–5).”
BackgroundInfluentialGenetic Study of Neurexin and Neuroligin Genes in Alzheimer's Disease
Martinez-Mir, A., Initiative, A. D. N., González-Pérez, A., Gayán, J., Antúnez, C., Marín, J., Boada, M., Lopez-Arrieta, J. M., Fernández, E., Ramírez-Lorca, R., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122257 · Cited by 45
Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review
Huq, A. J., Fransquet, P., Laws, S. M., Ryan, J., Sebra, R., Masters, C. L., Winship, I. M., James, P. A., & Lacaze, P. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.05.011 · Cited by 35
“[18] OR for CUBP2 A in APOE ε4/ε4 cases and controls 5 1.”
BackgroundKunkle, B. W., Jaworski, J., Barral, S., Vardarajan, B., Beecham, G. W., Martin, E. R., Cantwell, L. S., Partch, A., Bird, T. D., Raskind, W. H., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.020 · Cited by 32
Self-citationCell type-specific functions of Alzheimer's disease endocytic risk genes
Maninger, J.-K., Nowak, K., Goberdhan, S., O'Donoghue, R., & Connor-Robson, N. (2024) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2022.0378 · Cited by 22
Metadata
- Authors
- Wijsman, E. M., Pankratz, N. D., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R., Goate, A. M., Farlow, M., Ghetti, B., Sweet, R. A., Foroud, T. M., Mayeux, R., & The NIA-LOAD/NCRAD Family Study Group
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-17
- Volume
- 7
- Issue
- 2
- Pages
- e1001308
- ISSN
- 1553-7404
- PMC
- PMC3040659
- Cited by
- 214
- References
- 34
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.